All Around Winning With Mikhail Blagosklonny

In many ways Mikhail Blagosklonny is one of the best friends that a person can have if they or someone they love is suffering from about a dozen ailments including that of getting old. His research involves the drug Sirolimus which has so many properties and curative abilities that it is hard to believe this drug was once used as an antifungal agent. Mankind has the Easter Islands and the decade of the 1970s to thank for its discovery and initial applications. It is extracted from a bacteria found on the islands.

Sirolimus and Mikhail Blagosklonny work well together because both the doctor and the medicine perform on multiple levels and treat multiple ailments. The doctor himself is a professor of Oncology at the Rosewell Park Cancer Institute in Buffalo, New York, and he’s also the editor-in-chief of Oncotarget with a dedicated mission to the eradicate cancer. Sirolimus is a drug that has curative properties for many illnesses, but is also in its research phase for this function. When the doctor is not actually practicing his medicine trying to save lives he is advertently advocating others to do the same by any means necessary within reason. That is to day that he is a reasonable man and professional. This not that only makes him a professor and a researcher, but it makes him a philanthropist as well. Read more on Impact Journals.

One of the main focuses of his research is the most puzzling question as to why cancer affects the elderly than those in the spring of their life. Intriguingly enough, he also researches ways to find uses for Sirolimus that may extend the human lifespan. His ultimate professional goal and lifelong dream is to find a way to see a world in which cancer treatment is not a tragic and long experience but something that is easily treated and administered on a regular basis. Fortunately, for the rest of the world this drug that he works with so well has a about a dozen different uses.


To begin with, it has immunosuppressant abilities which make it great for transplant patients who have a really hard time keeping the organs gifted to them due to the humans body’s natural tendency to reject foreign objects. It is also a method of treatment for the disease Lymphangioleiomyomatosis which affects women of a particular age by piggybacking on a sclerosis gene within the lung tissue. It is also good for Coronary Stent Coating and facial angiofibromas. But, that’s not all it does as there are a few studies in the research phase that may find further uses for this drug.

These elements include Alzheimer’s, muscular dystrophy and SLE commonly known as lupus. It’s a good thing that dr. Mikhail Blagosklonny is a well-rounded man because anyone who wants to find the full uses of this drug is going to have to show imagination, innovation and pure care for their patients which Mikhail does naturally. With the respect of his colleagues and many professional organizations within the field, all this good doctor needs is someone else to begin working and finish the labor of the he has started. Read Mikhail’s plans for Oncology on

Leave a Reply

Your email address will not be published. Required fields are marked *